Citius Pharmaceuticals Inc. Common (CTXR) is a publicly traded Healthcare sector company. As of August 6, 2026, CTXR trades at $0.64 with a market cap of $17.09M and a P/E ratio of -0.35. CTXR moved -21.86% today. Year to date, CTXR is +0.50%; over the trailing twelve months it is -42.16%. Its 52-week range spans $0.47 to $5.95. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces CTXR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CTXR shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.64 |
| Market Cap | $17.09M |
| P/E Ratio | -0.35 |
| EPS | $-2.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.95 |
| 52-Week Low | $0.47 |
| Volume | 1.21M |
| Avg Volume | 0 |
| Revenue (TTM) | $5.61M |
| Net Income | $-55.45M |
| Gross Margin | 0.00% |
1 analysts cover CTXR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.